Noticias

Noticias

  • Título: QT Vascular initiates Chocolate Cases in Singapore
  • Fecha: 06-05-2014

  • SINGAPORE, May 6, 2014 /PRNewswire/ -- QT Vascular Ltd. (QT Vascular) is pleased to announce that it has started clinical cases with the Chocolate® PTA balloon catheter (Chocolate® PTA) in Singapore. Five cases were performed at National University Hospital (NUH) and Changi General Hospital (CGH).

    Speaking after the procedures, Dr. Steven Kum, a vascular surgeon at CGH and an expert in treating peripheral arterial disease (PAD), stated, 'After treating several patients with severe disease both above and below the knee, I believe that Chocolate PTA has an important role in the peripheral lab as it offers less traumatic treatment without the use of a permanent implant. I'm also very excited about the potential for the Drug-Coated Chocolate balloon for below the knee disease that is more common inSingapore because there are no adequate treatment options for those patients.'

    Added Dr. Julian Wong, Division head, Vascular & Endovascular Surgery at NUH, 'I truly agree with Dr. Kum. Chocolate PTA gives a more uniform angioplasty result with less intimal dissection. It has a great potential in reducing the use of stents in complex lesions below and above the knee.'

    According to Singapore Health Services, PAD is a major cause of limb loss (amputation) in Singapore. However, it does not receive as much attention as diseases involving the other vascular beds, namely coronary artery disease and cerebrovascular disease (1).

    The Chocolate® PTA design represents a breakthrough in PTA balloon catheters. The Chocolate® PTA is used for the treatment of patients with vascular disease in their legs, known as PAD. It was designed to provide predictable, uniform, less traumatic dilatation of peripheral vasculature. The Chocolate® PTA has demonstrated a very low rate of dissections and bail-out stenting in clinical studies in the United States(2).

    QT Vascular's product pipeline includes a Drug-Coated Chocolate balloon. It combines the acute benefits of the Chocolate® PTA with paclitaxel-based coating, an anti-proliferative drug that has been shown to be efficacious in the prevention of re-narrowing of the artery over time.

    'The cases performed at these prestigious institutions mark a key milestone in QT Vascular's journey to bring improved PAD treatment options to patients,' said Dr. Eitan Konstantino, Chief Executive Officer of QT Vascular, 'We are very excited to treat patients in Singapore, our home base.'



  • Fuente: endovascular.es